Pliant Therapeutics Inc (9PT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
| Previous close | 12.50 |
| Open | 12.30 |
| Bid | 12.70 x N/A |
| Ask | 13.20 x N/A |
| Day's range | 12.30 - 12.30 |
| 52-week range | 10.80 - 25.00 |
| Volume | |
| Avg. volume | 12 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)
Pliant Therapeutics ( NASDAQ:PLRX ) First Quarter 2024 Results Key Financial Results Net loss: US$47.0m (loss widened...
- Zacks
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
Pliant Therapeutics, Inc. (PLRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares
Keith Cummings, the CFO of Pliant Therapeutics Inc, sold 9,781 shares of the company on January 17, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.